Suhaila O. Alhaj‐Suliman

New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization

Amer Ali Abd El‐Hafeez, Kareem Ebeid, Aml I. Mekkawy et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2022 · 55 citations · Full text

Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine

Rasheid Smith, Emad I. Wafa, Sean M. Geary et al. · Science Advances · 2022 · 34 citations · Full text

Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAFV600E melanoma-bearing mice

Aml I. Mekkawy, Youssef W. Naguib, Suhaila O. Alhaj‐Suliman et al. · International Journal of Pharmaceutics · 2021 · 21 citations · Full text

Nanomedicine, Tumor Biology, Paclitaxel Anticancer Activity +10

Ciprofloxacin Derivative‐Loaded Nanoparticles Synergize with Paclitaxel Against Type II Human Endometrial Cancer

Youssef W. Naguib, Suhaila O. Alhaj‐Suliman, Emad I. Wafa et al. · Small · 2023 · 17 citations · Full text

A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer

Suhaila O. Alhaj‐Suliman, Youssef W. Naguib, Emad I. Wafa et al. · Biomaterials · 2023 · 15 citations · Full text

Oncology, Medicine, Pharmacology +6